Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)

E. L. K. Voogt, S. Nordkamp, A. G. J. Aalbers, T. Buffart, G. J. Creemers, C. A. M. Marijnen, C. Verhoef, K. Havenga, F. A. Holman, M. Kusters, A. W. K. S. Marinelli, J. Melenhorst, N. Abdul Aziz, N. Abecasis, M. Abraham-Nordling, T. Akiyoshi, W. Alberda, M. Albert, M. Andric, E. AngeneteA. Antoniou, R. Auer, K. K. Austin, G. L. Beets, R. G. H. Beets-Tan, M. Berbee, J. Berg, P. L. Berg, J. G. Bloemen, D. Collins, M. Davies, M. de Vries, H. Grabsch, K. Horsthuis, J. Houwers, K. Keymeulen, M. S. Khan, N. F. M. Kok, S. Kumar, P. J. Lee, P. J. Nilsson, S. Oei, A. C. Peterson, H. M. U. Peulen, J. J. G. Slangen, E. J. Tan, L. van Iersel, D. van Zoggel, J. M. W. E. Willems, H. J. T. Rutten, PelvEx Collaborative, J.W.A. Burger*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number029
Number of pages10
JournalBJS Open
Volume5
Issue number3
DOIs
Publication statusPublished - May 2021

Keywords

  • TOTAL MESORECTAL EXCISION
  • METASTATIC COLORECTAL-CANCER
  • FOLFOXIRI PLUS BEVACIZUMAB
  • 1ST-LINE TREATMENT
  • PHASE-II
  • CONCOMITANT CHEMORADIOTHERAPY
  • MULTIMODALITY TREATMENT
  • POOLED ANALYSIS
  • OXALIPLATIN
  • SURGERY

Cite this